These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 25641666)
1. A pharmacokinetic model of oral methylphenidate in the rat and effects on behavior. Thanos PK; Robison LS; Steier J; Hwang YF; Cooper T; Swanson JM; Komatsu DE; Hadjiargyrou M; Volkow ND Pharmacol Biochem Behav; 2015 Apr; 131():143-53. PubMed ID: 25641666 [TBL] [Abstract][Full Text] [Related]
2. Weekday-only chronic oral methylphenidate self-administration in male rats: Reversibility of the behavioral and physiological effects. Carias E; Fricke D; Vijayashanthar A; Smith L; Somanesan R; Martin C; Kalinowski L; Popoola D; Hadjiargyrou M; Komatsu DE; Thanos PK Behav Brain Res; 2019 Jan; 356():189-196. PubMed ID: 30149034 [TBL] [Abstract][Full Text] [Related]
3. Chronic oral methylphenidate treatment reversibly increases striatal dopamine transporter and dopamine type 1 receptor binding in rats. Robison LS; Ananth M; Hadjiargyrou M; Komatsu DE; Thanos PK J Neural Transm (Vienna); 2017 May; 124(5):655-667. PubMed ID: 28116523 [TBL] [Abstract][Full Text] [Related]
4. Brief and extended abstinence from chronic oral methylphenidate treatment produces reversible behavioral and physiological effects. Kalinowski L; Connor C; Somanesan R; Carias E; Richer K; Smith L; Martin C; Mackintosh M; Popoola D; Hadjiargyrou M; Komatsu DE; Thanos PK Dev Psychobiol; 2020 Mar; 62(2):170-180. PubMed ID: 31456229 [TBL] [Abstract][Full Text] [Related]
5. Sex Differences in the Physiological and Behavioral Effects of Chronic Oral Methylphenidate Treatment in Rats. Robison LS; Michaelos M; Gandhi J; Fricke D; Miao E; Lam CY; Mauceri A; Vitale M; Lee J; Paeng S; Komatsu DE; Hadjiargyrou M; Thanos PK Front Behav Neurosci; 2017; 11():53. PubMed ID: 28400722 [TBL] [Abstract][Full Text] [Related]
6. Recovery from behavior and developmental effects of chronic oral methylphenidate following an abstinence period. Martin C; Fricke D; Vijayashanthar A; Lowinger C; Koutsomitis D; Popoola D; Hadjiargyrou M; Komatsu DE; Thanos PK Pharmacol Biochem Behav; 2018 Sep; 172():22-32. PubMed ID: 30030127 [TBL] [Abstract][Full Text] [Related]
7. Brain kinetics of methylphenidate (Ritalin) enantiomers after oral administration. Ding YS; Gatley SJ; Thanos PK; Shea C; Garza V; Xu Y; Carter P; King P; Warner D; Taintor NB; Park DJ; Pyatt B; Fowler JS; Volkow ND Synapse; 2004 Sep; 53(3):168-75. PubMed ID: 15236349 [TBL] [Abstract][Full Text] [Related]
9. Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents. Thanos PK; Michaelides M; Benveniste H; Wang GJ; Volkow ND Pharmacol Biochem Behav; 2007 Oct; 87(4):426-33. PubMed ID: 17599397 [TBL] [Abstract][Full Text] [Related]
10. Comparison between intraperitoneal and oral methylphenidate administration: A microdialysis and locomotor activity study. Gerasimov MR; Franceschi M; Volkow ND; Gifford A; Gatley SJ; Marsteller D; Molina PE; Dewey SL J Pharmacol Exp Ther; 2000 Oct; 295(1):51-7. PubMed ID: 10991960 [TBL] [Abstract][Full Text] [Related]
11. Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. Kuczenski R; Segal DS J Neurosci; 2002 Aug; 22(16):7264-71. PubMed ID: 12177221 [TBL] [Abstract][Full Text] [Related]
12. A 90-day oral gavage toxicity study of d-methylphenidate and d,l-methylphenidate in beagle dogs. Teo SK; Stirling DI; Thomas SD; Evans MG; Khetani VD Int J Toxicol; 2003; 22(3):215-26. PubMed ID: 12851154 [TBL] [Abstract][Full Text] [Related]
13. Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Brandon CL; Marinelli M; Baker LK; White FJ Neuropsychopharmacology; 2001 Nov; 25(5):651-61. PubMed ID: 11682248 [TBL] [Abstract][Full Text] [Related]
14. Effects of perinatal methylphenidate (MPH) treatment on postweaning behaviors of male and female Sprague-Dawley rats. Ferguson SA; Delbert Law C; Sahin L; Montenegro SV Neurotoxicol Teratol; 2015; 47():125-36. PubMed ID: 25514582 [TBL] [Abstract][Full Text] [Related]
15. Abstinence from Chronic Methylphenidate Exposure Modifies Cannabinoid Receptor 1 Levels in the Brain in a Dose-dependent Manner. Connor C; Hamilton J; Robison L; Hadjiargyrou M; Komatsu D; Thanos P Curr Pharm Des; 2022; 28(4):331-338. PubMed ID: 33504296 [TBL] [Abstract][Full Text] [Related]
16. Effects of perinatal methylphenidate (MPH) treatment in male and female Sprague-Dawley offspring. Panos JJ; Law CD; Ferguson SA Neurotoxicol Teratol; 2014; 42():9-16. PubMed ID: 24444667 [TBL] [Abstract][Full Text] [Related]
17. Chronic treatment and abstinence from methylphenidate exposure dose-dependently changes glucose metabolism in the rat brain. Richer K; Hamilton J; Delis F; Martin C; Fricke D; Yao R; Sajjad M; Blum K; Hadjiargyrou M; Komatsu D; Thanos PK Brain Res; 2022 Apr; 1780():147799. PubMed ID: 35074404 [TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of methylphenidate in children with attention-deficit hyperactivity disorder. Shader RI; Harmatz JS; Oesterheld JR; Parmelee DX; Sallee FR; Greenblatt DJ J Clin Pharmacol; 1999 Aug; 39(8):775-85. PubMed ID: 10434228 [TBL] [Abstract][Full Text] [Related]
19. Chronic oral methylphenidate treatment in adolescent rats promotes dose-dependent effects on NMDA receptor binding. Jalloh K; Roeder N; Hamilton J; Delis F; Hadjiargyrou M; Komatsu D; Thanos PK Life Sci; 2021 Jan; 264():118708. PubMed ID: 33186568 [TBL] [Abstract][Full Text] [Related]
20. Abstinence following intermittent methylphenidate exposure dose-dependently modifies brain glucose metabolism in the rat brain. Arnavut E; Hamilton J; Yao R; Sajjad M; Hadjiargyrou M; Komatsu D; Thanos PK Synapse; 2022 Aug; 76(9-10):17-30. PubMed ID: 35730134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]